chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Myalgia, Pain in extremity, Paraesthesia
Clinical narrative: Light pain in the left leg; Muscles hurting; Pins and needles down trough the foot; Numb toes; Numbness in the left leg; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) in the right arm on 06Apr2021 at 09:45 (at the age of 49-year-old) as a dose for COVID-19 immunisation. Medical history included low back pain and femoral neuropathy (left side). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pregabalin (MANUFACTURER UNKNOWN) 50 mg, two times a day, thyroid (ARMOUR THYROID) from unknown start dates for unknown indications and ibuprofen (MANUFACTURER UNKNOWN) 600 (UNSPECIFIED UNIT) every 8 hours from 06Apr2021 for an unknown indication. The patient had no known allergies to medications, food, or other products. On 06Apr2021, few hours after the vaccination, the patient experienced light pain in the left leg where the patient was diagnosed with neuropathy 2 years ago following a car accident. The pain continued to increase till 23:00 and the patient was crawling in pain in the bed. The patient experienced the left leg was numb with pins and needles down through the foot. The patient rated the pain at 9. The patient experienced numb toes and heavy legs which stayed to 16Apr. The patient experienced muscle pain and numbness which was so high that the patient was afraid of losing the leg. The patient was then able to decrease the ibuprofen (MANUFACTURER UNKNOWN) intake but was still needed 75 mg of pregabalin (MANUFACTURER UNKNOWN) morning and evening. The patient wanted to know if it was safe to get the second dose of vaccination. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events light pain in left leg, muscles hurting, pins and needles down through the foot, numb toes and numbness in the left leg were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus, Persistent ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 13:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 01:00, the patient experienced tinnitus. The patient had persistent ringing in ears. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tinnitus, persistent ringing in ears was not resolved at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Erythema, Fatigue, Incorrect route of product administration, Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen lymph nodes under arms, painful; Swollen lymph nodes under arms, painful and red; Light fatigue and tiredness; Low pain at site of injection; Swollen lymph nodes under arms; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 10Apr2021 at 10:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to bee stings. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 11Apr2021 at 18:00, following the day of vaccination, the patient experienced swollen lymph nodes under arms which were painful, red and uncomfortable when trying to sleep. The under arms was very tender, had some light fatigue, tiredness and low pain at site of injection. The swollen lymph nodes were persisted even after more than a week at the time of the report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen lymph nodes under arms, painful and red, light fatigue and tiredness and low pain at site of injection was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oedema peripheral, Sleep disorder, Swelling
Clinical narrative: Swollen lymph nodes under arms, painful; Swollen lymph nodes under arms, painful and red; Light fatigue and tiredness; Low pain at site of injection; Swollen lymph nodes under arms; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 10Apr2021 at 10:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to bee stings. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 11Apr2021 at 18:00, following the day of vaccination, the patient experienced swollen lymph nodes under arms which were painful, red and uncomfortable when trying to sleep. The under arms was very tender, had some light fatigue, tiredness and low pain at site of injection. The swollen lymph nodes were persisted even after more than a week at the time of the report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen lymph nodes under arms, painful and red, light fatigue and tiredness and low pain at site of injection was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Erythema, Fatigue, Lymph node pain, Lymphadenopathy, Vaccination site pain
Clinical narrative: Swollen lymph nodes under arms, painful; Swollen lymph nodes under arms, painful and red; Light fatigue and tiredness; Low pain at site of injection; Swollen lymph nodes under arms; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 10Apr2021 at 10:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to bee stings. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 11Apr2021 at 18:00, following the day of vaccination, the patient experienced swollen lymph nodes under arms which were painful, red and uncomfortable when trying to sleep. The under arms was very tender, had some light fatigue, tiredness and low pain at site of injection. The swollen lymph nodes were persisted even after more than a week at the time of the report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen lymph nodes under arms, painful and red, light fatigue and tiredness and low pain at site of injection was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Contusion, Dysmenorrhoea, Fatigue, Feeling abnormal, Headache
Clinical narrative: Bruising toes on right foot; Sharp menstrual cramps; Feeling as if in daze; Barely keep eyes open; Low-grade Fever 100 degrees F; Nausea; Fatigue; Continuous dull headache; Pain in arm surrounding where shot was administered; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 11:00, immediate 24-48 hours of vaccination, the patient experienced bruising toes on right foot, low-grade fever 100 degrees Fahrenheit (F), sharp menstrual cramps (the patient was in menopause), nausea, pain in arm surrounding where shot was administered and felt as if was in daze. The patient experienced continuous dull headache, fatigue still on day 6 following the vaccine which had the concerned the patient, as the headache and fatigue was not going away. The patient could barely keep her eyes open. It was reported that other symptoms had ceased. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of events. The clinical outcome of the events continuous dull headache, fatigue and barely keep eyes open were not recovered at the time of reporting. The clinical outcome of the events bruising toes on right foot, low-grade fever 100 degrees Fahrenheit, sharp menstrual cramps, nausea, pain in arm surrounding where shot was administered and feeling as if in daze were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site pain, Nausea, Pyrexia
Clinical narrative: Bruising toes on right foot; Sharp menstrual cramps; Feeling as if in daze; Barely keep eyes open; Low-grade Fever 100 degrees F; Nausea; Fatigue; Continuous dull headache; Pain in arm surrounding where shot was administered; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 11:00, immediate 24-48 hours of vaccination, the patient experienced bruising toes on right foot, low-grade fever 100 degrees Fahrenheit (F), sharp menstrual cramps (the patient was in menopause), nausea, pain in arm surrounding where shot was administered and felt as if was in daze. The patient experienced continuous dull headache, fatigue still on day 6 following the vaccine which had the concerned the patient, as the headache and fatigue was not going away. The patient could barely keep her eyes open. It was reported that other symptoms had ceased. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of events. The clinical outcome of the events continuous dull headache, fatigue and barely keep eyes open were not recovered at the time of reporting. The clinical outcome of the events bruising toes on right foot, low-grade fever 100 degrees Fahrenheit, sharp menstrual cramps, nausea, pain in arm surrounding where shot was administered and feeling as if in daze were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature, Contusion, Dysmenorrhoea, Fatigue, Feeling abnormal
Clinical narrative: Bruising toes on right foot; Sharp menstrual cramps; Feeling as if in daze; Barely keep eyes open; Low-grade Fever 100 degrees F; Nausea; Fatigue; Continuous dull headache; Pain in arm surrounding where shot was administered; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 11:00, immediate 24-48 hours of vaccination, the patient experienced bruising toes on right foot, low-grade fever 100 degrees Fahrenheit (F), sharp menstrual cramps (the patient was in menopause), nausea, pain in arm surrounding where shot was administered and felt as if was in daze. The patient experienced continuous dull headache, fatigue still on day 6 following the vaccine which had the concerned the patient, as the headache and fatigue was not going away. The patient could barely keep her eyes open. It was reported that other symptoms had ceased. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of events. The clinical outcome of the events continuous dull headache, fatigue and barely keep eyes open were not recovered at the time of reporting. The clinical outcome of the events bruising toes on right foot, low-grade fever 100 degrees Fahrenheit, sharp menstrual cramps, nausea, pain in arm surrounding where shot was administered and feeling as if in daze were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Nausea, Pyrexia, Somnolence, Vaccination site pain
Clinical narrative: Bruising toes on right foot; Sharp menstrual cramps; Feeling as if in daze; Barely keep eyes open; Low-grade Fever 100 degrees F; Nausea; Fatigue; Continuous dull headache; Pain in arm surrounding where shot was administered; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 11:00, immediate 24-48 hours of vaccination, the patient experienced bruising toes on right foot, low-grade fever 100 degrees Fahrenheit (F), sharp menstrual cramps (the patient was in menopause), nausea, pain in arm surrounding where shot was administered and felt as if was in daze. The patient experienced continuous dull headache, fatigue still on day 6 following the vaccine which had the concerned the patient, as the headache and fatigue was not going away. The patient could barely keep her eyes open. It was reported that other symptoms had ceased. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of events. The clinical outcome of the events continuous dull headache, fatigue and barely keep eyes open were not recovered at the time of reporting. The clinical outcome of the events bruising toes on right foot, low-grade fever 100 degrees Fahrenheit, sharp menstrual cramps, nausea, pain in arm surrounding where shot was administered and feeling as if in daze were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Contusion, Dysmenorrhoea, Fatigue, Headache, Muscle spasms
Clinical narrative: Bruising toes on right foot; Sharp menstrual cramps; Feeling as if in daze; Barely keep eyes open; Low-grade Fever 100 degrees F; Nausea; Fatigue; Continuous dull headache; Pain in arm surrounding where shot was administered; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 11:00, immediate 24-48 hours of vaccination, the patient experienced bruising toes on right foot, low-grade fever 100 degrees Fahrenheit (F), sharp menstrual cramps (the patient was in menopause), nausea, pain in arm surrounding where shot was administered and felt as if was in daze. The patient experienced continuous dull headache, fatigue still on day 6 following the vaccine which had the concerned the patient, as the headache and fatigue was not going away. The patient could barely keep her eyes open. It was reported that other symptoms had ceased. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of events. The clinical outcome of the events continuous dull headache, fatigue and barely keep eyes open were not recovered at the time of reporting. The clinical outcome of the events bruising toes on right foot, low-grade fever 100 degrees Fahrenheit, sharp menstrual cramps, nausea, pain in arm surrounding where shot was administered and feeling as if in daze were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Bruising toes on right foot; Sharp menstrual cramps; Feeling as if in daze; Barely keep eyes open; Low-grade Fever 100 degrees F; Nausea; Fatigue; Continuous dull headache; Pain in arm surrounding where shot was administered; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 11:00, immediate 24-48 hours of vaccination, the patient experienced bruising toes on right foot, low-grade fever 100 degrees Fahrenheit (F), sharp menstrual cramps (the patient was in menopause), nausea, pain in arm surrounding where shot was administered and felt as if was in daze. The patient experienced continuous dull headache, fatigue still on day 6 following the vaccine which had the concerned the patient, as the headache and fatigue was not going away. The patient could barely keep her eyes open. It was reported that other symptoms had ceased. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of events. The clinical outcome of the events continuous dull headache, fatigue and barely keep eyes open were not recovered at the time of reporting. The clinical outcome of the events bruising toes on right foot, low-grade fever 100 degrees Fahrenheit, sharp menstrual cramps, nausea, pain in arm surrounding where shot was administered and feeling as if in daze were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram ambulatory, Embolism arterial, Thromboembolectomy
Clinical narrative: On 7/22, I was admitted to the hospital due to suffering stroke like symptoms. I was later diagnosed as having a mini stroke in my thalamus. As a result, they went looking to see why I had this stroke. They did CT w contrasts and a series of other tests. They discovered a massive clot in my aorta. I had previously had a portion of my aorta replaced. There was a mechanical failure in the old aortic replacement. I had a genetic mutation. When I spoke to the surgeon, He said it was a combination of my genetic mutation, the mechanical failure and the vaccine that caused my symptoms. I had open heart surgery on 8/9 to remove the clot in my aorta. Hospital, 7 days. Second hospital, 3 days.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Peripheral artery thrombosis, Scan with contrast
Clinical narrative: On 7/22, I was admitted to the hospital due to suffering stroke like symptoms. I was later diagnosed as having a mini stroke in my thalamus. As a result, they went looking to see why I had this stroke. They did CT w contrasts and a series of other tests. They discovered a massive clot in my aorta. I had previously had a portion of my aorta replaced. There was a mechanical failure in the old aortic replacement. I had a genetic mutation. When I spoke to the surgeon, He said it was a combination of my genetic mutation, the mechanical failure and the vaccine that caused my symptoms. I had open heart surgery on 8/9 to remove the clot in my aorta. Hospital, 7 days. Second hospital, 3 days.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aortic thrombosis, Aortic valve replacement, Blood test, Cardiac operation, Computerised tomogram
Clinical narrative: On 7/22, I was admitted to the hospital due to suffering stroke like symptoms. I was later diagnosed as having a mini stroke in my thalamus. As a result, they went looking to see why I had this stroke. They did CT w contrasts and a series of other tests. They discovered a massive clot in my aorta. I had previously had a portion of my aorta replaced. There was a mechanical failure in the old aortic replacement. I had a genetic mutation. When I spoke to the surgeon, He said it was a combination of my genetic mutation, the mechanical failure and the vaccine that caused my symptoms. I had open heart surgery on 8/9 to remove the clot in my aorta. Hospital, 7 days. Second hospital, 3 days.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head abnormal, Computerised tomogram thorax abnormal, Device failure, Echocardiogram, Gene mutation
Clinical narrative: On 7/22, I was admitted to the hospital due to suffering stroke like symptoms. I was later diagnosed as having a mini stroke in my thalamus. As a result, they went looking to see why I had this stroke. They did CT w contrasts and a series of other tests. They discovered a massive clot in my aorta. I had previously had a portion of my aorta replaced. There was a mechanical failure in the old aortic replacement. I had a genetic mutation. When I spoke to the surgeon, He said it was a combination of my genetic mutation, the mechanical failure and the vaccine that caused my symptoms. I had open heart surgery on 8/9 to remove the clot in my aorta. Hospital, 7 days. Second hospital, 3 days.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neurological symptom, Scan with contrast abnormal, Transient ischaemic attack
Clinical narrative: On 7/22, I was admitted to the hospital due to suffering stroke like symptoms. I was later diagnosed as having a mini stroke in my thalamus. As a result, they went looking to see why I had this stroke. They did CT w contrasts and a series of other tests. They discovered a massive clot in my aorta. I had previously had a portion of my aorta replaced. There was a mechanical failure in the old aortic replacement. I had a genetic mutation. When I spoke to the surgeon, He said it was a combination of my genetic mutation, the mechanical failure and the vaccine that caused my symptoms. I had open heart surgery on 8/9 to remove the clot in my aorta. Hospital, 7 days. Second hospital, 3 days.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness when stand up; Dizziness when move too fast; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 04Apr2021 at 10:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included aortic stenosis. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included valsartan (MANUFACTURER UNKNOWN) on an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 13Mar2021 at 12:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. On 12Apr2021, the patient experienced dizziness when moved too fast or stood up. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events which included prescribed medications for dizziness. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness when stand up and dizziness when move too fast was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dizziness postural
Clinical narrative: Dizziness when stand up; Dizziness when move too fast; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 04Apr2021 at 10:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included aortic stenosis. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included valsartan (MANUFACTURER UNKNOWN) on an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 13Mar2021 at 12:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. On 12Apr2021, the patient experienced dizziness when moved too fast or stood up. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events which included prescribed medications for dizziness. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness when stand up and dizziness when move too fast was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Headache, Libido decreased, Lymphadenopathy, Myalgia
Clinical narrative: hurts throat; Hurts right ear; swelling in lymph nodes; Woke up with headache; muscle pain; low energy; weak; Felt light headed; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies to food, medications or other products. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 15:00 the patient felt light headed and weak. On 22Apr2021 the patient woke up with headache, muscle pain and low energy. On 23Apr2021 the muscle pain was reducing, energy levels were restoring but headache was constant and now developed swelling in lymph nodes and hurt in throat and right ear. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event felt light headed, weak, low energy and muscle pain was recovering; while that of headache was not recovered. The clinical outcome of swelling in lymph nodes, hurts throat and right ear was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: hurts throat; Hurts right ear; swelling in lymph nodes; Woke up with headache; muscle pain; low energy; weak; Felt light headed; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies to food, medications or other products. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 15:00 the patient felt light headed and weak. On 22Apr2021 the patient woke up with headache, muscle pain and low energy. On 23Apr2021 the muscle pain was reducing, energy levels were restoring but headache was constant and now developed swelling in lymph nodes and hurt in throat and right ear. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event felt light headed, weak, low energy and muscle pain was recovering; while that of headache was not recovered. The clinical outcome of swelling in lymph nodes, hurts throat and right ear was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Ear pain, Headache, Lymphadenopathy
Clinical narrative: hurts throat; Hurts right ear; swelling in lymph nodes; Woke up with headache; muscle pain; low energy; weak; Felt light headed; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies to food, medications or other products. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 15:00 the patient felt light headed and weak. On 22Apr2021 the patient woke up with headache, muscle pain and low energy. On 23Apr2021 the muscle pain was reducing, energy levels were restoring but headache was constant and now developed swelling in lymph nodes and hurt in throat and right ear. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event felt light headed, weak, low energy and muscle pain was recovering; while that of headache was not recovered. The clinical outcome of swelling in lymph nodes, hurts throat and right ear was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Oropharyngeal pain
Clinical narrative: hurts throat; Hurts right ear; swelling in lymph nodes; Woke up with headache; muscle pain; low energy; weak; Felt light headed; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies to food, medications or other products. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 15:00 the patient felt light headed and weak. On 22Apr2021 the patient woke up with headache, muscle pain and low energy. On 23Apr2021 the muscle pain was reducing, energy levels were restoring but headache was constant and now developed swelling in lymph nodes and hurt in throat and right ear. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event felt light headed, weak, low energy and muscle pain was recovering; while that of headache was not recovered. The clinical outcome of swelling in lymph nodes, hurts throat and right ear was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Electrocardiogram normal, Fatigue, Headache, Tinnitus
Clinical narrative: Headache; Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 12:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 12:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 15:30, after three hours of vaccination, the patient experienced ringing in ears that was ongoing so far for five days. On 16Apr2021 at 16:30, after four hours of vaccination, the patient experienced headache that lasted about four hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measure was not taken as a result of the events. The clinical outcome of the event headache was resolved on 16Apr2021 at 20:30 while the outcome of the event ringing in ears was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Tinnitus
Clinical narrative: Headache; Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 12:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 12:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 15:30, after three hours of vaccination, the patient experienced ringing in ears that was ongoing so far for five days. On 16Apr2021 at 16:30, after four hours of vaccination, the patient experienced headache that lasted about four hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measure was not taken as a result of the events. The clinical outcome of the event headache was resolved on 16Apr2021 at 20:30 while the outcome of the event ringing in ears was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Erythema, Flushing, Lip swelling, Peripheral swelling, Skin warm
Clinical narrative: Swelling in face, lips, fingers; Warm to touch; Swelling in face, lips, fingers; Swelling in face, lips, fingers; Flush red arms and hands; This is a spontaneous report from a contactable consumer. A 16-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 13May2021 at 09:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, chronic urticaria. The patient had known allergies to penicillin (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included meningococcal vaccine (MANUFACTURER UNKNOWN) and salbutamol (VENTOLIN); all from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 22Apr2021 at 09:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient received any other vaccines within four weeks prior to the vaccination. On 13May2021 at 10:00, the patient experienced swelling in face, lips, fingers, flush red arms and hands and warm to touch. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events swelling in face, lips, fingers, flush red arms and hands and warm to touch were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.